鹭燕医药
(002788)
| 流通市值：34.13亿 | | | 总市值：34.85亿 |
| 流通股本：3.80亿 | | | 总股本：3.89亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 458,141,985.69 | 606,302,753.24 | 589,295,901.31 | 636,830,725.06 |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 5,866,750,910.67 | 5,637,073,695.29 | 5,721,291,504.99 | 5,835,936,792.23 |
| 其中：应收票据 | 0 | 0 | - | 2,985,000 |
| 应收账款 | 5,866,750,910.67 | 5,637,073,695.29 | 5,721,291,504.99 | 5,832,951,792.23 |
| 应收款项融资 | 17,807,849.78 | 35,953,467.25 | 29,937,372.76 | 9,446,351.66 |
| 预付款项 | 439,755,842.88 | 314,917,160.74 | 353,375,466.84 | 433,009,772.89 |
| 其他应收款合计 | 115,255,602.82 | 94,591,181.12 | 68,063,286.11 | 99,480,747.55 |
| 其中:应收利息 | 0 | 0 | - | - |
| 应收股利 | 0 | 0 | - | - |
| 存货 | 2,528,472,661.18 | 2,574,076,489.37 | 2,256,781,668.15 | 2,288,408,504.08 |
| 合同资产 | 0 | 0 | - | - |
| 一年内到期的非流动资产 | 0 | 0 | - | - |
| 其他流动资产 | 55,369,519.3 | 55,658,877.1 | 46,773,362.92 | 44,254,771.99 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,481,554,372.32 | 9,318,573,624.11 | 9,065,518,563.08 | 9,347,367,665.46 |
| 非流动资产: | | | | |
| 债权投资 | 0 | 0 | - | - |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 0 | 0 | - | - |
| 长期股权投资 | 49,552,514.42 | 43,552,514.42 | 43,125,675.14 | 43,125,675.14 |
| 其他权益工具投资 | 300,000 | 300,000 | 5,300,000 | 5,300,000 |
| 其他非流动金融资产 | 5,000,000 | 5,000,000 | - | - |
| 投资性房地产 | 23,551,114.53 | 23,777,500.02 | 24,031,180.49 | 24,257,477.93 |
| 固定资产 | 986,535,209.11 | 917,097,492.64 | 919,843,765.79 | 807,780,491.06 |
| 在建工程 | 588,550,602.78 | 616,586,162.43 | 520,260,291.37 | 577,009,820.91 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 134,786,609.2 | 119,250,798.72 | 111,902,939.59 | 105,474,810.45 |
| 无形资产 | 358,203,453.07 | 355,163,568.35 | 342,718,711.68 | 186,489,583.85 |
| 开发支出 | 0 | 0 | - | - |
| 商誉 | 288,651,455.27 | 288,651,455.27 | 288,651,455.27 | 288,651,455.27 |
| 长期待摊费用 | 29,272,518.41 | 28,584,076.52 | 27,837,728.66 | 27,778,830.47 |
| 递延所得税资产 | 71,507,202.76 | 66,373,991.23 | 72,406,577.15 | 69,056,297.87 |
| 其他非流动资产 | 3,716,047.61 | 10,683,277.64 | - | 9,250 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,539,626,727.16 | 2,475,020,837.24 | 2,356,078,325.14 | 2,134,933,692.95 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 12,021,181,099.48 | 11,793,594,461.35 | 11,421,596,888.22 | 11,482,301,358.41 |
| 流动负债: | | | | |
| 短期借款 | 4,156,458,316.83 | 3,990,156,064.21 | 4,492,458,925.39 | 4,529,302,453.44 |
| 交易性金融负债 | 0 | 0 | - | - |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 3,447,518,938.61 | 3,444,468,056.11 | 2,676,454,552.84 | 2,794,810,995.8 |
| 其中：应付票据 | 1,181,736,475.98 | 1,113,806,554.25 | 782,243,940.05 | 731,650,734.85 |
| 应付账款 | 2,265,782,462.63 | 2,330,661,501.86 | 1,894,210,612.79 | 2,063,160,260.95 |
| 预收款项 | 33,200 | 23,371.24 | 7,187.75 | 5,917.25 |
| 合同负债 | 24,635,367.8 | 22,356,122.94 | 62,600,330.11 | 43,396,917.92 |
| 应付职工薪酬 | 39,678,707.35 | 65,454,170.74 | 45,662,919.67 | 47,241,609.7 |
| 应交税费 | 72,362,875.33 | 68,989,289.4 | 63,788,382.63 | 50,945,090.38 |
| 其他应付款合计 | 220,330,559.4 | 234,636,779.85 | 254,042,582.42 | 259,815,681.04 |
| 其中:应付利息 | 0 | 0 | - | - |
| 应付股利 | 0 | 0 | - | 4,897,066.64 |
| 一年内到期的非流动负债 | 215,820,695.3 | 197,206,741.78 | 71,109,969.51 | 63,452,253.7 |
| 其他流动负债 | 3,119,385.69 | 2,867,281.25 | 8,124,323.74 | 5,431,258.4 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 8,179,958,046.31 | 8,026,157,877.52 | 7,674,249,174.06 | 7,794,402,177.63 |
| 非流动负债: | | | | |
| 长期借款 | 566,299,561.03 | 578,628,801.23 | 638,006,363.36 | 618,473,773.18 |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 98,775,298.13 | 74,328,563.18 | 79,677,539.43 | 69,552,475.13 |
| 长期应付款 | 86,723,677.07 | 90,977,952.37 | 101,085,157.44 | 104,485,301.33 |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 39,480,503.65 | 39,755,570.83 | 40,110,820.04 | 40,434,687.84 |
| 递延所得税负债 | 6,714,731.51 | 6,805,044.1 | 6,848,783.63 | 6,915,809.7 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 797,993,771.39 | 790,495,931.71 | 865,728,663.9 | 839,862,047.18 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 8,977,951,817.7 | 8,816,653,809.23 | 8,539,977,837.96 | 8,634,264,224.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 388,516,736 | 388,516,736 | 388,516,736 | 388,516,736 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 616,220,833.39 | 631,048,081.18 | 636,489,349.34 | 653,766,038.28 |
| 减:库存股 | 0 | 0 | - | - |
| 其他综合收益 | 3,847,716.92 | 3,842,541.98 | 4,040,836.2 | 4,160,673.45 |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 199,283,211.92 | 199,283,211.92 | 184,609,253.75 | 184,609,253.75 |
| 未分配利润 | 1,807,344,238.29 | 1,723,567,806.87 | 1,636,687,368.45 | 1,563,725,111.49 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,015,212,736.52 | 2,946,258,377.95 | 2,850,343,543.74 | 2,794,777,812.97 |
| 少数股东权益 | 28,016,545.26 | 30,682,274.17 | 31,275,506.52 | 53,259,320.63 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,043,229,281.78 | 2,976,940,652.12 | 2,881,619,050.26 | 2,848,037,133.6 |
| 负债和股东权益合计 | 12,021,181,099.48 | 11,793,594,461.35 | 11,421,596,888.22 | 11,482,301,358.41 |
| 公告日期 | 2024-04-16 | 2024-04-16 | 2023-10-24 | 2023-08-08 |
| 审计意见(境内) | | 标准无保留意见 | | |